In another study, plasma CCL3 and CXCL10 levels were higher in COVID-19 patients with pneumonia and hypoxia requiring oxygen supplementation compared to patients without pneumonia and patients with pneumonia but not experiencing hypoxia (Young et al., 2020). This evidence concerns the gene CXCL10 and susceptibility to pneumonia measurement.